activity
20192022
most citedRobust multiple comparisons against a control group with application in toxicology

7 citations · 22 across the 17 of their papers we have counts for

collaborators

17 papers

stat.ME20222 cited

Seven recommendations for alternatives to the common analysis of variance (ANOVA) with application in the life sciences -- using R

Ludwig A. Hothorn

Standard ANOVA is among the most widely used tests in the life sciences and beyond. Several alternatives are proposed to provide simultaneous confidence intervals, ensure tight con…

stat.ME20221 cited

Simultaneous confidence intervals for the interpretation of primary and secondary effects in factorial designs without a pre-test on interaction

Ludwig A. Hothorn

The analysis of low dimensional factorial designs with possible interactions is a relevant issue. Instead of the common pre-tests for interaction, a simultaneous inference procedur…

stat.AP2022

Evaluation of histological findings with severity grade, to analyze toxicology in-vivo studies

Ludwig A. Hothorn, Klaus Weber

In-vivo toxicological studies are characterized by multiple primary endpoints with quite different scales. Whereas guidelines and publications provide various statistical tests for…

stat.AP2021

Closed testing procedures for treatment-versus-control comparisons and multiple correlated endpoint

Ludwig A. Hothorn, Siegfried Kropf

Preferably in two- or three-arm randomized clinical trials, a few (2,3) correlated multiple primary endpoints are considered. In addition to the closed testing principle based on d…

stat.ME2021

Simultaneous comparisons of treatments versus control (Dunnett-type tests) for location-scale alternatives

Ludwig A. Hothorn

Commonly, the comparisons of treatment groups versus a control is performed for location effects only where possible scale effects are considered as disturbing. Sometimes scale eff…

stat.AP20211 cited

A statistical method for estimating the no-observed-adverse-event-level

Ludwig A. Hothorn

In toxicological risk assessment the benchmark dose (BMD) is recommended instead of the no-observed-adverse effect-level (NOAEL). Still a simple test procedure to estimate NOAEL is…